Physician
Sky Lakes Medical Center INC
Sky Lakes Medical Center INC was paid $30.27M by Medicaid between Jan 2018 and Dec 2024, across 286 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.
33Billing provider infoSKY LAKES MEDICAL CENTER INC
KLAMATH FALLS, OR 97601
KLAMATH FALLS, OR 97601
33aNPI1659340370assigned 03/15/2006
33bProvider typeGeneral Practice Physician
28Total paid$30.27M
24GClaims1,036,901
24DCodes billed286
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Practice Physician providers in Oregon
Rank by total paid#3 of 23
Median peer was paid$112K
This provider vs. median271×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 119,494 | $3.06M | |
| 2019 | 143,542 | $3.96M | |
| 2020 | 133,323 | $4.08M | |
| 2021 | 174,174 | $4.84M | |
| 2022 | 185,740 | $5.34M | |
| 2023 | 171,792 | $5.18M | |
| 2024incomplete | 108,836 | $3.81M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 61,323 | 48,838 | $7.04M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 72,204 | 55,858 | $6.51M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 19% | 23,156 | 19,367 | $5.61M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.8% | 35,215 | 26,710 | $1.75M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.6% | 13,077 | 11,910 | $1.39M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.9% | 177,222 | 152,742 | $1.19M |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 2.6% | 809 | 722 | $777K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.7% | 42,763 | 37,959 | $501K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.6% | 75,210 | 67,831 | $470K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 26,476 | 21,721 | $363K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.0% | 3,459 | 3,163 | $308K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,691 | 1,232 | $290K |
274 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 7,010 | $258K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 37,928 | $220K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,509 | $216K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,192 | $192K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 3,343 | $186K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 5,118 | $152K |
| 99205 | Prolong outpt/office vis | <1% | 546 | $136K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 10,121 | $132K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 11,554 | $131K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,519 | $122K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,497 | $107K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,275 | $102K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 2,337 | $97K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 955 | $94K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,045 | $85K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,941 | $81K |
| 76641 | <1% | 2,581 | $79K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,357 | $77K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,903 | $69K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 311 | $67K |
| 76830 | Ultrasound, transvaginal | <1% | 2,140 | $65K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 720 | $64K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 828 | $62K |
| 76813 | <1% | 705 | $57K | |
| 99070 | <1% | 2,618 | $55K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 16,904 | $55K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 65,985 | $47K |
| 90686 | <1% | 3,298 | $46K | |
| 96415 | <1% | 1,156 | $44K | |
| 0012A | <1% | 1,783 | $43K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,759 | $43K |
| 80053 | Comprehensive metabolic panel | <1% | 44,868 | $40K |
| 0011A | <1% | 1,484 | $36K | |
| 0002A | <1% | 1,175 | $30K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 602 | $30K |
| 72110 | <1% | 630 | $29K | |
| 0001A | <1% | 1,016 | $28K | |
| 0064A | <1% | 1,127 | $26K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,085 | $26K |
| 99201 | <1% | 667 | $25K | |
| 73630 | <1% | 1,445 | $24K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,209 | $18K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 557 | $17K |
| 87806 | <1% | 990 | $16K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 874 | $16K |
| 73610 | <1% | 834 | $14K | |
| 92557 | <1% | 647 | $14K | |
| 80074 | <1% | 888 | $13K | |
| 73030 | <1% | 1,093 | $13K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 4,229 | $12K |
| 76536 | <1% | 545 | $12K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 74 | $12K |
| J3490 | Unclassified drugs | <1% | 324 | $12K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 8,810 | $11K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 24 | $10K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 39 | $10K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 141 | $10K |
| 77066 | Tomosynthesis, mammo | <1% | 247 | $9K |
| 17000 | <1% | 967 | $9K | |
| 72100 | <1% | 931 | $9K | |
| 76770 | <1% | 327 | $9K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 124 | $9K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 11,114 | $8K |
| 81001 | <1% | 21,588 | $8K | |
| 0004A | <1% | 382 | $8K | |
| 96158 | <1% | 408 | $8K | |
| 0072A | <1% | 197 | $8K | |
| 93976 | <1% | 217 | $8K | |
| 97597 | <1% | 579 | $8K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 78,721 | $7K |
| 0071A | <1% | 187 | $7K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 166 | $7K |
| 73564 | <1% | 159 | $7K | |
| 73130 | <1% | 758 | $7K | |
| 29848 | <1% | 13 | $7K | |
| 72050 | <1% | 117 | $7K | |
| 0240U | <1% | 554 | $7K | |
| 93971 | <1% | 444 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,401 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,933 | $6K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,073 | $6K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 106 | $6K |
| 52000 | <1% | 76 | $6K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 955 | $6K |
| 73562 | <1% | 740 | $6K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 163 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 65 | $5K |
| 74018 | <1% | 665 | $5K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 1,018 | $5K |
| 84484 | <1% | 10,411 | $5K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 143 | $5K |
| 11102 | <1% | 192 | $5K | |
| 86900 | <1% | 383 | $4K | |
| 31575 | <1% | 73 | $4K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 138 | $4K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 582 | $4K |
| 90837 | Psychotherapy session, about an hour | <1% | 37 | $4K |
| 0031A | <1% | 117 | $4K | |
| 83690 | <1% | 8,241 | $4K | |
| 99170 | <1% | 99 | $4K | |
| 80061 | Lipid panel | <1% | 4,613 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,262 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,673 | $3K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 247 | $3K |
| 73502 | <1% | 308 | $3K | |
| 73110 | <1% | 223 | $3K | |
| 77065 | Tomosynthesis, mammo | <1% | 93 | $3K |
| 93970 | <1% | 145 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,341 | $3K |
| 96156 | <1% | 77 | $3K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 60 | $3K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 3,634 | $3K |
| 72141 | <1% | 13 | $2K | |
| 71250 | <1% | 93 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 237 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 976 | $2K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 62 | $2K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 884 | $2K |
| 71270 | <1% | 15 | $2K | |
| 96152 | <1% | 73 | $2K | |
| 87486 | <1% | 885 | $2K | |
| 87581 | <1% | 885 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,261 | $2K |
| 92550 | <1% | 106 | $2K | |
| 90677 | <1% | 14 | $2K | |
| 76801 | <1% | 28 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 129 | $1K |
| 0054A | <1% | 82 | $1K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 169 | $1K |
| 80076 | <1% | 2,495 | $1K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 753 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,279 | $1K |
| 92567 | <1% | 137 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 578 | $1K |
| 82652 | <1% | 218 | $1K | |
| 77080 | <1% | 216 | $1K | |
| 87634 | <1% | 48 | $1K | |
| 93227 | <1% | 104 | $1K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 108 | $1K |
| 93307 | <1% | 62 | $1K | |
| 86592 | <1% | 1,173 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 503 | $955.88 |
| 17003 | <1% | 390 | $937.70 | |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | <1% | 147 | $924.73 |
| 93296 | <1% | 63 | $873.94 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 376 | $785.82 |
| 94060 | <1% | 51 | $775.67 | |
| J2704 | Injection, propofol, 10 mg | <1% | 288 | $771.69 |
| 96127 | <1% | 1,485 | $718.16 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 248 | $701.25 |
| 96150 | <1% | 15 | $694.69 | |
| 80306 | <1% | 2,062 | $694.24 | |
| 0450 | Emergency room services | <1% | 30 | $693.00 |
| 95251 | <1% | 28 | $679.55 | |
| 93356 | <1% | 193 | $674.73 | |
| 73221 | <1% | 13 | $643.19 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 31 | $632.29 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 951 | $610.14 |
| 80047 | <1% | 2,395 | $563.74 | |
| 72040 | <1% | 55 | $514.42 | |
| 96159 | <1% | 45 | $509.64 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 108 | $459.01 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 234 | $450.01 |
| 99443 | <1% | 109 | $402.98 | |
| 0051A | <1% | 13 | $400.00 | |
| 90715 | <1% | 20 | $395.41 | |
| 86850 | <1% | 472 | $394.01 | |
| 85610 | <1% | 1,125 | $370.09 | |
| 86140 | <1% | 2,863 | $366.76 | |
| 76882 | <1% | 15 | $345.42 | |
| 83605 | <1% | 767 | $343.80 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 44 | $342.80 |
| 99221 | <1% | 28 | $338.28 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 15 | $317.87 |
| 85027 | <1% | 1,402 | $306.45 | |
| 0013A | <1% | 18 | $306.00 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 12 | $301.11 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 443 | $278.12 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 786 | $271.41 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 112 | $262.21 |
| 94726 | <1% | 54 | $260.01 | |
| 86780 | <1% | 199 | $258.81 | |
| 99223 | Prolong inpt eval add15 m | <1% | 49 | $258.21 |
| 99417 | Prolong home eval add 15m | <1% | 49 | $241.12 |
| 90670 | <1% | 13 | $224.04 | |
| 93294 | <1% | 15 | $221.67 | |
| 73560 | <1% | 31 | $219.33 | |
| 85652 | <1% | 3,057 | $215.01 | |
| 84703 | <1% | 1,919 | $203.90 | |
| 93000 | <1% | 38 | $201.01 | |
| 94729 | <1% | 56 | $198.39 | |
| 93922 | <1% | 26 | $191.66 | |
| 81025 | <1% | 356 | $160.39 | |
| 99442 | <1% | 223 | $155.99 | |
| 81003 | <1% | 655 | $154.37 | |
| 84481 | <1% | 36 | $153.98 | |
| 51798 | <1% | 1,173 | $138.04 | |
| 82274 | <1% | 72 | $133.49 | |
| 72070 | <1% | 13 | $120.76 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 14 | $120.64 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 21 | $118.08 |
| 86769 | <1% | 76 | $107.85 | |
| 85379 | <1% | 286 | $104.42 | |
| 84145 | <1% | 203 | $103.76 | |
| 84439 | <1% | 224 | $100.91 | |
| 87522 | Neg quan hep c or qual rna | <1% | 150 | $98.03 |
| 87081 | <1% | 193 | $93.84 | |
| 87495 | <1% | 14 | $84.08 | |
| 77085 | <1% | 23 | $83.29 | |
| 82550 | <1% | 1,442 | $80.85 | |
| 83874 | <1% | 1,231 | $79.31 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 12 | $78.40 |
| 82728 | <1% | 274 | $76.32 | |
| 86901 | <1% | 383 | $72.88 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 106 | $66.49 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 194 | $60.96 |
| 87340 | <1% | 144 | $59.46 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 74 | $57.68 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 67 | $57.05 |
| 84702 | <1% | 402 | $56.71 | |
| 83880 | <1% | 683 | $54.27 | |
| 82553 | <1% | 1,345 | $53.27 | |
| 86160 | <1% | 79 | $50.40 | |
| 85730 | <1% | 105 | $49.58 | |
| 87070 | <1% | 72 | $47.19 | |
| 83615 | <1% | 225 | $45.38 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 86 | $40.96 |
| 82310 | <1% | 41 | $38.72 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 19 | $30.88 |
| 87186 | <1% | 27 | $12.25 | |
| 82947 | <1% | 17 | $10.20 | |
| 86225 | <1% | 39 | $9.62 | |
| 87088 | <1% | 78 | $8.72 | |
| 85049 | <1% | 75 | $7.35 | |
| 36416 | <1% | 140 | $7.12 | |
| 87077 | <1% | 14 | $7.08 | |
| 99441 | <1% | 118 | $7.04 | |
| 85007 | <1% | 12 | $5.32 | |
| 83735 | <1% | 192 | $4.69 | |
| 82950 | <1% | 14 | $3.69 | |
| 82962 | <1% | 48 | $2.49 | |
| 3074F | 0% | 593 | $0.00 | |
| 86762 | 0% | 47 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 82 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 87 | $0.00 |
| 3075F | 0% | 28 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 32 | $0.00 |
| 3079F | 0% | 129 | $0.00 | |
| 0305 | 0% | 16 | $0.00 | |
| 96376 | 0% | 76 | $0.00 | |
| 82607 | 0% | 12 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 45 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 40 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 13 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 49 | $0.00 |
| 99024 | 0% | 141 | $0.00 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 18 | $0.00 |
| 0301 | 0% | 14 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 0% | 12 | $0.00 |
| 86706 | 0% | 27 | $0.00 | |
| 0250 | 0% | 39 | $0.00 | |
| 86704 | 0% | 22 | $0.00 | |
| 3078F | 0% | 451 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 26 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 113 | $0.00 |
| 84100 | 0% | 14 | $0.00 | |
| 83655 | 0% | 12 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 102 | $0.00 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 41 | $0.00 |
| 88112 | 0% | 60 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 71 | $0.00 |
| 0300 | 0% | 17 | $0.00 | |
| 87902 | 0% | 19 | $0.00 | |
| 99152 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRICO, RICHARD (VP)
| Provider | Location | Paid |
|---|---|---|
| West Physician Services LLC | Klamath Falls, OR | $280K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.